Bayer has launched a new ultra-modern office in the Ikeja, Lagos. The investment demonstrates Bayer’s long-term commitment to Nigeria, its clients and the industries that it operates in, the company said.
Bayer is a multinational pharmaceutical, chemical, health and life sciences company.
The new office reflects the expansion of its business in Nigeria while meeting the occupancy needs of the company. “The new office design is an epitome of modern architecture and an embodiment of global and local workplace standards,” the company said.
“It was constructed to the Bayer Group’s specifications in terms of quality, functionality and resilience. Staff have a variety of workplaces to support different types of work activities and styles.”
These, the company said, range from collaboration spaces, team desks to more private focus desks, which staff can select for their most appropriate needs during the day, providing the flexibility to balance their professional and personal lives. Modern meeting rooms and facilities create conducive environment for the customer focused discussions with clients and partners, the company said.
In 2014, as part of the company’s Africa strategy, Bayer decided to strengthen its presence in Nigeria. This strategy saw the company expand its operations in West Africa to include offices in Accra/Ghana, Lagos/Nigeria and Abidjan/Ivory Coast, (regional headquarters). Beyond these offices, Bayer now also has representatives in West Africa countries. Bayer Middle Africa (Nig) Ltd, the legal entity and a subsidiary of Bayer AG (Germany), operates with Lagos as its hub but also have representatives across all regions of the country.
All three divisions of Bayer Pharmaceuticals, Consumer Health and CropScience are present in Nigeria.
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. The Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of €35.0 billion. Capital expenditures amounted to €2.4 billion, while R&D expenses were €4.5 billion.
